Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Novavax Inc
(NQ:
NVAX
)
132.50
USD
+1.04 (+0.79%)
Streaming Delayed Price
Updated: 7:35 AM EST, Jan 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Novavax Inc
< Previous
1
2
3
4
5
6
7
8
9
...
71
72
Next >
Return On Capital Employed Overview: Novavax
December 11, 2020
During Q3, Novavax's (NASDAQ: NVAX) reported sales totaled $157.02 million. Despite a 1039.03% in earnings, the company posted a ...
Tags
News
NVAX
Market News
From
Benzinga
These 5 Mid-Cap Healthcare Stocks Had the Best Gains in 2020
December 11, 2020
Investors favored coronavirus vaccine work, late-stage trial victories, and genetic sequencing.
Tags
MRNA
INO
ARCT
From
Motley Fool
3 Best Biotech Stocks of 2020: Are They Buys Now?
December 10, 2020
There are plenty of catalysts on the horizon for these investments -- and a healthy dose of risk.
Tags
PFE
NVAX
Market News
From
Motley Fool
Forget Moderna! These 2 Stocks May be the Biggest Winners of the Vaccine Race
December 10, 2020
A biotech company and a big pharma player each offer something that sets them apart from rivals.
Tags
JNJ
MRNA
NVAX
From
Motley Fool
Moderna Analyst Positive On Coronavirus Vaccine Progress, Downgrades Shares On Valuation
December 09, 2020
Moderna Inc (NASDAQ: MRNA) has been one of the best performing stocks of 2020thanks to its COVID-19 vaccine development ...
Tags
Biotech
Movers
Alan Carr
From
Benzinga
Looking For The Best Biotech Stocks To Buy Now? 2 Up By Over 300% YTD
December 08, 2020
From
Stockmarket.com
Analyzing Novavax's Unusual Options Activity
December 08, 2020
Shares of Novavax (NASDAQ: NVAX) saw some unusual options activity on Tuesday. Following the unusual option alert, the stock price moved ...
Tags
Options
Markets
Market News
From
Benzinga
Why Novavax Stock Crushed It in November
December 08, 2020
A rival's setback could translate into a major windfall for this mid-cap biotech company.
Tags
AZN
IBB
NVAX
From
Motley Fool
How to Buy Coronavirus Vaccine Stocks in 2021
December 08, 2020
Are the big gains over? No. But the game is changing.
Tags
Market News
NVAX
MRNA
From
Motley Fool
$40 Billion COVID Vaccine Market in 2021: These 3 Stocks Are Likely to Be the Biggest Winners
December 08, 2020
The companies with the biggest gains won't necessarily be those with the highest sales of coronavirus vaccines.
Tags
MRNA
NVAX
Market News
From
Motley Fool
Bill Gates Says 6 COVID-19 Vaccines Likely To Get Regulatory Approval By Q1
December 08, 2020
Microsoft Corporation (NASDAQ: MSFT) co-founder Bill Gates said that nearly half a dozen vaccines from different manufacturers could be ...
Tags
Media
BNTX
Biotech
From
Benzinga
I’m already trying out a COVID vaccine. But can I get another one injected, in case it was a placebo?
December 08, 2020
"Will I be inoculated against coronavirus twice --- with two different vaccines? Or will I, on the other hand, miss my chance altogether?" writes Pierre Briançon of volunteering for a vaccine trial in...
Tags
PFE
BNTX
NVAX
From
MarketWatch
Is Novavax Still a Buy After Jumping 3,000%?
December 07, 2020
The No. 1 stock of 2020 still has a lot of room to run... and a lot of room to fall.
Tags
Market News
NVAX
From
Motley Fool
AstraZeneca Follows Pfizer In Seeking India Emergency Use Approval For COVID-19 Vaccine
December 06, 2020
AstraZeneca Plc’s (NASDAQ: AZN) partner,the Serum Institute of India, applied for emergency use authorization of the ...
Tags
Government
General
Biotech
From
Benzinga
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
December 06, 2020
Biotech stocks headed higher in the week ended Dec. 5 as broader market optimism pervaded into the sector. The sector also continued to ...
Tags
BCRX
VERU
VRTX
From
Benzinga
This COVID Vaccine Stock Has Been the Biggest Millionaire-Maker by Far
December 06, 2020
You'll probably be surprised at just great the returns from investing in this stock have been.
Tags
AZN
PFE
Market News
From
Motley Fool
The Flu Gives This Coronavirus Vaccine Stock A Surprising Edge
December 05, 2020
Combining vaccines for multiple viruses could boost sales.
Tags
SNY
MRNA
NVAX
From
Motley Fool
3 Coronavirus Vaccine Stocks That Still Have Strong Upside
December 05, 2020
These three could deliver big for investors once their vaccines are approved for sale.
Tags
Market News
NVAX
PFE
From
Motley Fool
Here's the Dark Horse in the COVID Vaccine Race That You'll Want to Watch
December 05, 2020
Don't be surprised if this small biotech takes off in 2021.
Tags
NVAX
Market News
ARCT
From
Motley Fool
2 Reasons It's Not Too Late to Buy Moderna
December 04, 2020
There's more ahead than just a regulatory green light.
Tags
JNJ
VXRT
XLV
From
Motley Fool
Pfizer And Moderna Face Their Biggest Challenge: Vaccinating The World
December 03, 2020
In less than a year, Pfizer and Moderna did what usually takes drugmakers decades. But the coronavirus vaccine stocks now face a hurdle: Vaccinating the world.
From
Investor's Business Daily
2 Surprising Coronavirus Vaccine Stocks to Buy Right Now
December 03, 2020
If we judge by return on investment, these two mid-cap biotechs may be the ultimate winners of the coronavirus vaccine race.
Tags
NVAX
Market News
MRNA
From
Motley Fool
As Biotech Thrives On Vaccine Hopes, Traders Look Into The Sector's Diversity
December 02, 2020
If there is one prevailing trend that Wall Street is counting on during this period of great economic and social uncertainty, it’s ...
Tags
vantagepoint
Benzinga
MRNA
From
Benzinga
Why We Need All 5 of These Coronavirus Vaccine Companies to End the Pandemic
December 02, 2020
It's time to count how many vaccine doses leading companies can provide -- and how many may be needed.
Tags
JNJ
MRNA
PFE
From
Motley Fool
COVID Vaccine Stocks Update: Where Things Stand Now
December 02, 2020
Here's what you need to know about all of the leaders in the coronavirus vaccine race.
Tags
JNJ
MRNA
CVAC
From
Motley Fool
Noteworthy Tuesday Option Activity: NVAX, RGS, INSP
December 01, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Novavax, Inc. (NVAX), where a total volume of 42,989 contracts has been traded thus...
Tags
Stocks
From
Market News Video
Want to Invest in Coronavirus Vaccines? Consider This First
December 01, 2020
The differences between the vaccines could affect the eventual winner (if there is one).
Tags
PFE
AZN
JNJ
From
Motley Fool
Could These Biotech Stocks Be A Bigger COVID-19 Vaccine Winner Than Pfizer?
December 01, 2020
From
Stockmarket.com
2 Ultra-Risky Coronavirus Stocks That Could Make You Filthy Rich
December 01, 2020
They'll be later to market than rivals. But if their product candidates are stronger, investors may reap rewards.
Tags
NVAX
Market News
VIR
From
Motley Fool
Is Novavax Stock a Buy?
December 01, 2020
How much opportunity will exist for the company's vaccines by the time they are on the market?
Tags
NVAX
Market News
MRNA
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
71
72
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.